Dr. Peng Miao, Chinese Academy of Sciences, Suzhou Institute of Biomedical Engineering and Technology, China
Dr. Chaoqun Zhang, South China Agricultural University, China
Neuropathologist of Pathologists of Cardiovascular Pathology Unit, Sudden Infant Death Syndrome (SIDS) and Sudden Intrauterine Unexplained Death (SIUD) Veneto Regional Center, NorthEast, Italy
Submit manuscript at www.itmedicalteam.pl/submissions/translational-biomedicine.html or send as an e-mail attachment to the Editorial Office at [email protected]
Aim and Scope
Translational Biomedicine is an international open access*, peer-reviewed academic journal with Journal Impact Factor 1.12. The Journal publishes original science-based research that advances communication between the scientific discovery and health improvement.
The journal covers the advancement intranslational medicine,molecular medicine, translational genomics,clinical genetics, Translational research & clinical intervention, Translational stroke, Translational Neuroscience, Translational Oncology, Cardiovascular science, Stem cellTranslational Medicineetc.
Translational Biomedicine is indexed and abstracted in the following databases:
Scimago, CiteFactor, SciLit, DeepDyve, Genamics JournalSeek, CrossRef, Journal TOC, Open J-Gate, Electronic Journals Library and many more.
Translational Biomedicine publishes original research or commentary on diseases with implications for treatment, where scientific ideas are translated into clinic trials or applications. Commentary on policy, regulation, education, legal and other issues, national or global medical bioinformation.
Translational Biomedicine welcomes research articles, case reports, comprehensive/mini reviews and short communications from basic sciences to clinical sciences.
Articles published in Translational Biomedicine have been cited by esteemed scholars and scientists all around the world. Translational Biomedicine has got h-index 12 , which means every article in Translational Biomedicine has got 12 average citations.